Trial Profile
A Retrospective DERMBIO Registry Comparing the Efficacy and Characteristics of Patients Initiating First-Time Treatment with Secukinumab or Ustekinumab
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 May 2018
Price :
$35
*
At a glance
- Drugs Secukinumab (Primary) ; Ustekinumab (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- 23 May 2018 New trial record